Metastatic Hypopharyngeal Carcinoma

1 clinical trials · Condition

Record	Firm	Date
Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population (NCT06997068)	Mayo Clinic	2025-07-09

Every clearance here is in the API, with alerts when new ones post.